Abstract:Objectives: Immunohistochemical evaluation of the effectiveness of bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD). Materials and methods: There have been examined bronchial mucosa biopsies taken endoscopically from 18 patients with obstructive pulmonary disease. The biopsies were fixed in 4% buffered formalin for 24-48 hours and paraffin inclusion was made using the standard technique. For each biopsy, there were performed 10 serial sections with a thickness of 5 μm. The sections were stained using morphological, histochemical and immunohistochemical methods. At three of the cases, the paraffin blocks were reconverted for the electron microscopy study, in order to assess subcellular details, with special reference to "target" cells involved in local immune response. Morphohistochemical and immunohistochemical analysis was effectuated on biopsies removed before and after the treatment with bronchodilators. Results: The analysis of the biopsies removed before treatment revealed the following aspects: degenerative alterations of the surface epithelium, loss of ciliary differentiation, absence of caliciform cells, hyperexfoliation, formation of pseudopapillary structures, degenerative lesions of the glands, mucoid and oncocytary metaplasia, stasis in the dilated blood vessels, partly hyalinized wall, multiforme chronic inflammatory infiltrate, myofibroblasts in the depth of lamina propria; argyrophilic basement membrane, fragmentation and lysis of elastic fibers, degranulated mast cells associated with inflammatory infiltrate, with electron-dense typical granules, inflammatory infiltrate with CD20 positive B-lymphocytes, arranged perivasculary and in the vicinity of the basement membrane; rare positive CD4 T-lymphocytes; reduced number of plasma cells. After treatment we found the following aspects: partial or complete regeneration of the covering epithelium, with the presence of cilia cells and occasionally of caliciform cells; remaining myofibroblastic reaction in the lamina propria; increased number of mast cells with minimal or no degranulation; immature, lamelled mast cells. Conclusions: The application of management principles in group therapy study was done by the study which aims to demonstrate the beneficial role in COPD therapy of combining a β2-agonist with an anticholinergic, obtaining in this way an additional bronchodilator effect, compared with the one obtained by administrating bronchodilators of type β2 agonists. Deepening the molecular and cellular mechanisms of COPD can lead to more effective methods for early detection of disease, pharmacotherapy targeted and effective conduct exacerbations.

Transcriptomic changes in GOLD grade 2 to 3 COPD with chronic bronchitis following metered cryospray

Comparison of genome-wide gene expression profiling by RNA Sequencing versus microarray in bronchial biopsies of COPD patients before and after inhaled corticosteroid treatment: does it provide new insights?

LSC Abstract – Systemic and Local Metabolomics Profiling Reveals Novel Insights into the Progression of Emphysema

Gene Expression Networks in COPD: Microrna and Mrna Regulation

Metabolomics Screening Identifies Reducedl-Carnitine to Be Associated with Progressive Emphysema

Abstract PR566

Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx

Identifying a nasal gene expression signature associated with hyperinflation and treatment response in severe COPD

Morphological study of bronchial mucosa in the chronic obstructive pulmonary disease under the influence of therapeutic algorithm

Pulmonary and Systemic Immune Profiles Following Lung Volume Reduction Surgery and Allogeneic Mesenchymal Stromal Cell Treatment in Emphysema

Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent

Gene Expression Profiling in Patients with Chronic Obstructive Pulmonary Disease and Lung Cancer

Inhaled Corticosteroids Selectively Alter the Microbiome and Host Transcriptome in the Small Airways of Patients with Chronic Obstructive Pulmonary Disease

Single-Cell Sequencing of Lung Macrophages and Monocytes Reveals Novel Therapeutic Targets in COPD

Effects of cannabis oil extract on immune response gene expression in human small airway epithelial cells (HSAEpC): implications for chronic obstructive pulmonary disease (COPD)

Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways

COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors

Bronchial Rheoplasty for Chronic Bronchitis: Results from a Canadian Feasibility Study with RheOx®

COPD lung studies of Nrf2 expression and the effects of Nrf2 activators

Mesenchymal stromal cell therapy in COPD: from bench to bedside